Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 September, 2018 11:48 IST
Zydus receives final approval from USFDA for Zolmitriptan tablets
Source: IRIS | 12 Jul, 2018, 10.37AM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the USFDA to market Zolmitriptan Tablets, 2.5 mg and 5 mg. It is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting and sensitivity to light/sound). It will be manufactured at the group's manufacturing facility at Moraiya, Ahmedabad.

In line with this, the group now has 203 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company declined Rs 2.55, or 0.69%, to trade at Rs 368.95. The total volume of shares traded was 37,256 at the BSE (10.24 a.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Fitch revises outlook on Tata Motors to negative; affirms at BB+ - 21-Sep-2018 10:55
State Bank of India and QCI sign MoU on Zero Defect Zero Effect Certification for MSMEs - 21-Sep-2018 09:50
TCS partners with The Training Room, UK - 21-Sep-2018 09:46
Strides Pharma Science gets ACCC approval for merger of Arrow and Apotex Australia - 20-Sep-2018 10:15
Bajaj Finserv ties up with Wochit - 20-Sep-2018 10:09
Glenmark Pharma inducted into DJSI Emerging Market 2018 - 19-Sep-2018 12:09
TVS Motor Co strengthens presence in Mexico - 19-Sep-2018 11:56
Himachal Futuristic Communications bags order worth Rs 6.11 bn - 19-Sep-2018 11:52
Tata Steel completes acquisition of Creative Port Development - 19-Sep-2018 11:48
SABIC acquires 24.99% stake in Clariant globally - 19-Sep-2018 11:45
Tata Power launches its VoiceBOT TINA - 19-Sep-2018 11:42
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer